OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $411,690 | -56.3% | 146,509 | -35.5% | 0.02% | -47.7% |
| Q3 2022 | $942,000 | +330.1% | 227,170 | +316.3% | 0.04% | +388.9% |
| Q2 2022 | $219,000 | +28.1% | 54,570 | +57.9% | 0.01% | +50.0% |
| Q1 2022 | $171,000 | -23.3% | 34,570 | +7.8% | 0.01% | -25.0% |
| Q4 2021 | $223,000 | +9.3% | 32,070 | +57.4% | 0.01% | -11.1% |
| Q3 2021 | $204,000 | -55.7% | 20,370 | -27.3% | 0.01% | -52.6% |
| Q1 2021 | $460,000 | -66.5% | 28,014 | -57.7% | 0.02% | -64.2% |
| Q4 2020 | $1,372,000 | +421.7% | 66,300 | +91.7% | 0.05% | +341.7% |
| Q3 2020 | $263,000 | -58.5% | 34,577 | -54.5% | 0.01% | -66.7% |
| Q2 2020 | $633,000 | +41.6% | 75,936 | -15.8% | 0.04% | +2.9% |
| Q1 2020 | $447,000 | – | 90,180 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |